Mar 27
|
Myriad Genetics (MYGN) Wins Foundational Patent for MRD Assay
|
Mar 27
|
Masimo (MASI) Plans Consumer Business Spin-Off to Drive Growth
|
Mar 26
|
Three Reasons to Retain Avantor (AVTR) Stock in Your Portfolio
|
Mar 26
|
Veeva Systems' (VEEV) Vault EDC Witnesses Increasing Adoption
|
Mar 26
|
Reasons to Add Veeva Systems (VEEV) to Your Portfolio Now
|
Mar 26
|
GE HealthCare (GEHC) to Sell IONIC's FDA-Cleared nCommand Lite
|
Mar 26
|
Charles River (CRL) Extends Gene Therapy Deal With NUS Medicine
|
Mar 25
|
Is this the Best Time to Add DaVita (DVA) to Your Portfolio?
|
Mar 24
|
Warren Buffett's Berkshire Hathaway Owns Over 25% of These 4 Companies (Hint: Apple Isn't One of Them)
|
Mar 22
|
Tandem Diabetes (TNDM) Gains From Innovation Amid Competition
|
Mar 22
|
Stryker (SYK) Acquires SERF SAS to Aid Its Orthopedic Segment
|
Mar 22
|
Thermo Fisher (TMO) Inks Deal to Develop Companion Diagnostics
|
Mar 22
|
Phibro Stock (PAHC) Rises 7% YTD: Will the Run Continue?
|
Mar 21
|
Here's Why You Should Retain Nevro (NVRO) Stock for Now
|
Mar 21
|
GE HealthCare (GEHC) Renews HealthCare Alliance With Hartford
|
Mar 21
|
DaVita HealthCare (DVA) Is Up 1.09% in One Week: What You Should Know
|
Mar 21
|
UnitedHealth (UNH) Faces Investigation Following Cyberattack
|
Mar 21
|
Reasons to Add Stryker (SYK) Stock in Your Portfolio Now
|
Mar 21
|
Revvity's (RVTY) New Launch to Boost Research Productivity
|
Mar 21
|
Here's Why You Should Retain National Vision (EYE) Stock Now
|